Join

Compare · PM vs VLON

PM vs VLON

Side-by-side comparison of Philip Morris International Inc (PM) and Vallon Pharmaceuticals Inc. (VLON): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both PM and VLON operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
  • PM is the larger of the two at $161.16B, about 5315.9x VLON ($30.3M).
  • PM has hit the wire 11 times in the past 4 weeks while VLON has been quiet.
  • PM has more recent analyst coverage (25 ratings vs 1 for VLON).
MetricPMVLON
Company
Philip Morris International Inc
Vallon Pharmaceuticals Inc.
Price
$164.15-3.00%
$12.00+2453.19%
Market cap
$161.16B
$30.3M
1M return
-0.86%
-
1Y return
-2.95%
-
Industry
Medicinal Chemicals and Botanical Products
Medicinal Chemicals and Botanical Products
Exchange
NYSE
NASDAQ
IPO
2021
News (4w)
11
0
Recent ratings
25
1
PM

Philip Morris International Inc

Philip Morris International Inc., through its subsidiaries, manufactures and sells cigarettes, other nicotine-containing products, smoke-free products, and related electronic devices and accessories. The company offers IQOS smoke-free products, including heated tobacco and nicotine-containing vapor products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, and Parliament HeatSticks brands, as well as under the Fiit and Miix licensed brands. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. It markets and sells its products in the European Union, Eastern Europe, the Middle East, Africa, South and Southeast Asia, East Asia, Australia, Latin America, and Canada. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

VLON

Vallon Pharmaceuticals Inc.

Vallon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of prescription drugs for central nervous system disorders. The company develops abuse-deterrent amphetamine immediate-release, an abuse-deterrent oral formulation of immediate-release dextroamphetamine for the treatment of attention-deficit/hyperactivity disorder and narcolepsy. It also develops ADMIR, an abuse deterrent formulation of Ritalin. Vallon Pharmaceuticals, Inc. was incorporated in 2018 and is based in Philadelphia, Pennsylvania.

Latest PM

Latest VLON